Brief: Diasorin Q2 Adj. EBITDA EUR 107 Mln
31/07/2025 15:24
July 31 (Reuters) - DiaSorin SpA DIAS.MI: CONFIRMS GUIDANCE 2025 Q2 NET PROFIT EUR 46 MILLION Q2 ADJUSTED EBITDA EUR 107 MILLION Q2 REVENUE EUR 306 MILLION ESTIMATED IMPACT FROM TARIFFS ON GROUP’S PROFITABILITY FOR FY 2025 IS NOT EXPECTED TO BE MATERIAL Further company coverage: DIAS.MI (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21